MAZZOLARI, ANGELICA
MAZZOLARI, ANGELICA
Dipartimento di Scienze Farmaceutiche
A capture method based on the VC1 domain reveals new binding properties of the human receptor for advanced glycation end products (RAGE)
2017 G. Degani, A.A. Altomare, M. Colzani, C. Martino, A. Mazzolari, G. Fritz, G. Vistoli, L. Popolo, G. Aldini
Approaching pharmacological space: Events and components
2018 G. Vistoli, A. Pedretti, A. Mazzolari, B. Testa
Binding space concept : a new approach to enhance the reliability of docking scores and its application to predicting butyrylcholinesterase hydrolytic activity
2017 G. Vistoli, A. Mazzolari, B. Testa, A. Pedretti
Carbachol dimers as homobivalent modulators of muscarinic receptors
2016 R. Matucci, M. Nesi, M.V. Martino, C. Bellucci, D. Manetti, E. Ciuti, A. Mazzolari, S. Dei, L. Guandalini, E. Teodori, G. Vistoli, M.N. Romanelli
Carbachol dimers with primary carbamate groups as homobivalent modulators of muscarinic receptors
2020 R. Matucci, C. Bellucci, M.V. Martino, M. Nesi, D. Manetti, J. Welzel, U. Bartz, J. Holze, C. Tränkle, K. Mohr, A. Mazzolari, G. Vistoli, S. Dei, E. Teodori, M.N. Romanelli
Computational approaches in the rational design of improved carbonyl quenchers : focus on histidine containing dipeptides
2016 G. Vistoli, M. Colzani, A. Mazzolari, D.D. Maddis, G. Grazioso, A. Pedretti, M. Carini, G. Aldini
Cyclo(His-Pro) Exerts Protective Carbonyl Quenching Effects through Its Open Histidine Containing Dipeptides
2022 L. Regazzoni, L. Fumagalli, A. Artasensi, S. Gervasoni, E. Gilardoni, A. Mazzolari, G. Aldini, G. Vistoli
Data from docking simulations to develop an efficient strategy able to evaluate the interactions between RAGE and MDA-induced albumin adducts
2017 A. Mazzolari, C. Coppa, A. Altomare, G. Degani, G. Vistoli
Enhancing the reliability of GPCR models by accounting for flexibility of their pro-containing helices : The case of the human mAChR1 receptor
2015 A. Pedretti, A. Mazzolari, C. Ricci, G. Vistoli
FAME 3 : Predicting the Sites of Metabolism in Synthetic Compounds and Natural Products for Phase 1 and Phase 2 Metabolic Enzymes
2019 M. Sicho, C. Stork, A. Mazzolari, C. De Bruyn Kops, A. Pedretti, B. Testa, G. Vistoli, D. Svozil, J. Kirchmair
GLORYx : Prediction of the metabolites resulting from phase 1 and phase 2 biotransformations of xenobiotics
2021 C. de Bruyn Kops, M. Sicho, A. Mazzolari, J. Kirchmair
Hempseed (Cannabis sativa) Peptide H3 (IGFLIIWV) Exerts Cholesterol-Lowering Effects in Human Hepatic Cell Line
2022 J. Li, C. Bollati, M. Bartolomei, A. Mazzolari, A. Arnoldi, G. Vistoli, C. Lammi
Homology modeling and metabolism prediction of human carboxylesterase-2 using docking analyses by GriDock : a parallelized tool based on AutoDock 4.0
2010 G. Vistoli, A. Pedretti, A. Mazzolari, B. Testa
Impact of the Journal of Chemical Information and Modeling Special Issue on Women in Computational Chemistry
2020 A. Mazzolari, A. Nunes-Alves, H.A. Wahab, R.E. Amaro, Z. Cournia, K.M. Merz
Improvement of Topical Palmitoylethanolamide Anti-Inflammatory Activity by Pegylated Prodrugs
2015 D. Tronino, R. Russo, C. Ostacolo, A. Mazzolari, C. De Caro, C. Avagliano, S. Laneri, G. La Rana, A. Sacchi, F. Della Valle, G. Vistoli, A. Calignano
IN SILICO APPROACHES IN DRUG DESIGN AND DEVELOPMENT: APPLICATIONS TO RATIONAL LIGAND DESIGN AND METABOLISM PREDICTION
2015 A. Mazzolari
In silico prediction of human carboxylesterase-1 (hCES1) metabolism combining docking analyses and MD simulations
2010 G. Vistoli, A. Pedretti, A. Mazzolari, B. Testa
In silico prediction of metabolism by human carboxylesterase-1 (hCES1) combining docking analyses and MD simulations
2009 G. Vistoli, A. Pedretti, A. Mazzolari, B. Testa
Influence of ionization state on the activation of temocapril by hCES1: a molecular-dynamics study
2009 G. Vistoli, A. Pedretti, A. Mazzolari, C. Bolchi, B. Testa
Insights into the structural determinants required for high-affinity binding of chiral cyclopropane-containing ligands to α4β2-nicotinic acetylcholine receptors : an integrated approach to behaviorally active nicotinic ligands
2012 H. Zhang, J.B. Eaton, L. Yu, M. Nys, A. Mazzolari, R. van Elk, A.B. Smit, V. Alexandrov, T. Hanania, E. Sabath, A. Fedolak, D. Brunner, R.J. Lukas, G. Vistoli, C. Ulens, A.P. Kozikowski